AU3665893A - Sequences characteristic of human gene transcription product - Google Patents
Sequences characteristic of human gene transcription productInfo
- Publication number
- AU3665893A AU3665893A AU36658/93A AU3665893A AU3665893A AU 3665893 A AU3665893 A AU 3665893A AU 36658/93 A AU36658/93 A AU 36658/93A AU 3665893 A AU3665893 A AU 3665893A AU 3665893 A AU3665893 A AU 3665893A
- Authority
- AU
- Australia
- Prior art keywords
- human gene
- gene transcription
- transcription product
- sequences characteristic
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83719592A | 1992-02-12 | 1992-02-12 | |
US837195 | 2007-08-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3665893A true AU3665893A (en) | 1993-09-03 |
Family
ID=25273788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU36658/93A Abandoned AU3665893A (en) | 1992-02-12 | 1993-02-12 | Sequences characteristic of human gene transcription product |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3665893A (en) |
WO (1) | WO1993016178A2 (en) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0679716A4 (en) * | 1993-11-12 | 1999-06-09 | Kenichi Matsubara | Gene signature. |
WO1995018226A1 (en) | 1993-12-24 | 1995-07-06 | University Of Wales College Of Medicine | Tuberous sclerosis 2 gene and uses thereof |
US5605797A (en) * | 1994-09-15 | 1997-02-25 | Board Of Trustees Operating Michigan State University | Bovine β-mannosidase gene and methods of use |
US5863744A (en) * | 1994-10-03 | 1999-01-26 | New England Deaconess Hospital Corporation | Neural cell protein marker RR/B and DNA encoding same |
US5985598A (en) | 1994-10-27 | 1999-11-16 | Thomas Jefferson University | TCL-1 gene and protein and related methods and compositions |
US7175995B1 (en) | 1994-10-27 | 2007-02-13 | Thomas Jefferson University | TCL-1 protein and related methods |
US5985554A (en) * | 1994-11-02 | 1999-11-16 | Takeda Chemical Industries, Ltd. | Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides |
CA2225824A1 (en) * | 1995-06-30 | 1997-01-23 | Human Genome Sciences, Inc. | Breast specific genes and proteins |
US5695937A (en) * | 1995-09-12 | 1997-12-09 | The Johns Hopkins University School Of Medicine | Method for serial analysis of gene expression |
US5866330A (en) | 1995-09-12 | 1999-02-02 | The Johns Hopkins University School Of Medicine | Method for serial analysis of gene expression |
AU4105396A (en) | 1995-11-02 | 1997-05-29 | Human Genome Sciences, Inc. | Mammary transforming protein |
US7217788B2 (en) | 1996-03-14 | 2007-05-15 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta polypeptides |
US6509170B1 (en) | 1996-03-14 | 2003-01-21 | Human Genome Sciences, Inc. | Polynucleotides encoding human tumor necrosis factor delta |
US6541224B2 (en) | 1996-03-14 | 2003-04-01 | Human Genome Sciences, Inc. | Tumor necrosis factor delta polypeptides |
US6468766B1 (en) * | 1996-03-15 | 2002-10-22 | President And Fellows Of Harvard College | Aortic carboxypeptidase-like polypeptide |
JP2000513212A (en) * | 1996-05-06 | 2000-10-10 | カイロン コーポレイション | The mammalian mid-limb comb (mammal Scm) acts as an oncogene |
WO1997042219A1 (en) * | 1996-05-08 | 1997-11-13 | Chiron Corporation | MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR |
ATE290595T1 (en) | 1996-07-12 | 2005-03-15 | Genentech Inc | GAMMA-HEREGULIN |
US5874285A (en) * | 1996-09-13 | 1999-02-23 | Incyte Pharmaceuticals, Inc. | Polynucleotide encoding a novel human nm23-like protein |
US5917028A (en) * | 1996-10-29 | 1999-06-29 | Incyte Pharmaceuticals, Inc. | Human phosphoprotein |
US5840559A (en) * | 1996-10-30 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Human spermidine/spermine N1-acetyltransferase |
US5889170A (en) * | 1997-01-31 | 1999-03-30 | Incyte Pharmaceuticals, Inc. | Human integral membrane protein |
US5939271A (en) | 1997-02-19 | 1999-08-17 | The Regents Of The University Of California | Netrin receptor |
US5955312A (en) * | 1997-02-24 | 1999-09-21 | Incyte Pharmaceuticals, Inc. | DNA encoding a novel microtubule-associated protein |
AU6439598A (en) * | 1997-02-26 | 1998-09-18 | Genetics Institute Inc. | Secreted proteins and polynucleotides encoding them |
US6171787B1 (en) * | 1997-06-26 | 2001-01-09 | Abbott Laboratories | Member of the TNF family useful for treatment and diagnosis of disease |
US5948619A (en) * | 1997-07-31 | 1999-09-07 | Incyte Pharmaceuticals, Inc. | Human zygin-1 |
WO1999009158A1 (en) * | 1997-08-13 | 1999-02-25 | Chugai Research Institute For Molecular Medicine, Inc. | PROTEIN HAVING Zn FINGER-LIKE MOTIF |
US6130068A (en) * | 1998-10-26 | 2000-10-10 | Immunex Corporation | Viral encoded semaphorin protein receptor DNA and polypeptides |
US6562949B1 (en) | 1997-10-28 | 2003-05-13 | Immunex Corporation | Antibodies to viral encoded semaphorin protein receptor polypeptides |
US7214497B2 (en) | 1997-10-28 | 2007-05-08 | Immunex Corporation | Viral encoded semaphorin protein receptor DNA and polypeptides |
WO1999021997A1 (en) * | 1997-10-28 | 1999-05-06 | Immunex Corporation | Viral encoded semaphorin protein receptor dna and polypeptides |
US6277565B1 (en) * | 1997-11-06 | 2001-08-21 | Millennium Pharmaceuticals, Inc. | OCT-3 gene encoding transporter-like molecules |
US5916753A (en) * | 1997-11-13 | 1999-06-29 | Incyte Pharmaceuticals, Inc. | SH3-containing proteins |
AU4930399A (en) | 1998-07-29 | 2000-02-21 | Kyowa Hakko Kogyo Co. Ltd. | Novel Polypeptide |
EP1119624A2 (en) | 1998-10-09 | 2001-08-01 | Genset | Nucleic acids encoding human cide-b protein and polymorphic markers thereof |
US6355788B1 (en) | 1998-10-15 | 2002-03-12 | Zymogenetics, Inc. | Follistatin-related protein zfsta2 |
CA2347968A1 (en) * | 1998-10-15 | 2000-04-20 | Zymogenetics, Inc. | Follistatin-related protein zfsta2 |
AU2183300A (en) * | 1998-12-18 | 2000-07-12 | Incyte Pharmaceuticals, Inc. | Lymphocytic membrane proteins |
IL178921A0 (en) * | 1998-12-24 | 2007-03-08 | Yeda Res & Dev | Caspase-8 interacting proteins |
GB9900167D0 (en) * | 1999-01-06 | 1999-02-24 | Univ Leeds | Wound an tissue healing and orofacial clefting |
DE19908423A1 (en) * | 1999-02-26 | 2000-08-31 | Deutsches Krebsforsch | Protein involved in the development of the CNS |
EP1144606A2 (en) * | 1999-03-09 | 2001-10-17 | Schering Aktiengesellschaft | Human nucleic acid and protein sequences obtained from endothelial cells |
CN1289525C (en) | 1999-09-10 | 2006-12-13 | 加利福尼亚大学董事会 | T2R-novel family of taste receptors |
US6558910B2 (en) * | 1999-09-10 | 2003-05-06 | The Regents Of The University Of California | SF, a novel family of taste receptors |
AU1340001A (en) | 1999-10-22 | 2001-05-08 | Wyeth | Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
US20030153015A1 (en) * | 2000-01-20 | 2003-08-14 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
WO2001055300A2 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
WO2001081361A1 (en) * | 2000-04-11 | 2001-11-01 | Cogent Neuroscience, Inc. | Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death |
EP1209229A1 (en) * | 2000-11-21 | 2002-05-29 | Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch | Gene involved in schizophrenia |
US20060063152A1 (en) | 2000-12-22 | 2006-03-23 | Osamu Ohara | Novel gene and protein encoded by the gene |
CA2443123A1 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
US7927597B2 (en) | 2001-04-10 | 2011-04-19 | Agensys, Inc. | Methods to inhibit cell growth |
WO2002094192A2 (en) | 2001-05-24 | 2002-11-28 | Human Genome Sciences, Inc. | Antibodies against tumor necrosis factor delta (april) |
WO2004016733A2 (en) | 2002-08-16 | 2004-02-26 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
EP4234698A3 (en) | 2010-05-06 | 2023-11-08 | Novartis AG | Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) antibodies |
US9290573B2 (en) | 2010-05-06 | 2016-03-22 | Novartis Ag | Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies |
SG11201401717VA (en) | 2011-11-04 | 2014-05-29 | Novartis Ag | Low density lipoprotein-related protein 6 (lrp6) - half life extender constructs |
-
1993
- 1993-02-12 WO PCT/US1993/001294 patent/WO1993016178A2/en active Application Filing
- 1993-02-12 AU AU36658/93A patent/AU3665893A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1993016178A2 (en) | 1993-08-19 |
WO1993016178A3 (en) | 1993-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3665893A (en) | Sequences characteristic of human gene transcription product | |
AU2240492A (en) | Sequences characteristic of human gene transcription product | |
AU4106193A (en) | Inflatable sheath for introduction of ultrasonic catheter | |
AU4277093A (en) | Clad metallurgical products and methods of manufacture | |
AU6042396A (en) | Amplification of nucleic acid sequences | |
AU6614696A (en) | Inhibition of gene expression | |
AU4331497A (en) | Oligomers which inhibit expression of interleukin genes | |
AU5669494A (en) | Human homolog of the e-cadherin gene and methods based thereon | |
AU1173195A (en) | Treatment of immunoregulatory disorders | |
AU6614596A (en) | Inhibition of gene expression | |
AU8153794A (en) | Methods of inhibiting autoimmune diseases | |
AU6092394A (en) | Amplification of nucleic acid sequences | |
AU6819194A (en) | Isolated dna elements that direct pistil-specific and anther-specific gene expression and methods of using same | |
AU2861892A (en) | Astrocyte-specific transcription of human genes | |
EP0731647A4 (en) | Treatment of an edible product with humectants | |
AU6010294A (en) | Modulators of gene expression | |
AU3362293A (en) | Control of gene transcription | |
AU6040296A (en) | Methods of inducing bef-1 transcription factor | |
AU7671394A (en) | Expression control sequences of the p-selectin gene | |
AU5845294A (en) | Novel process and intermediates for the preparation of prodrugs | |
AU4641393A (en) | Use of mtr gene sequences for expression of foreign genes | |
AU2548095A (en) | Human inhibitor of apoptosis gene 1 | |
AU672019B2 (en) | Method of integrating gene into chromosome of (lactobacillus delbrueckii) species and product of gene integration | |
AU4489196A (en) | Novel medical use of heme products | |
AU8007094A (en) | High pressure treatment of food |